about
Risk of second cancer following radiotherapy for prostate cancer: a population-based analysis.Neoadjuvant chemoradiation for esophageal cancer : Surgery improves locoregional control while response based on FDG-PET/CT predicts survival.Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence after radical prostatectomy.Influence of localization of PSMA-positive oligo-metastases on efficacy of metastasis-directed external-beam radiotherapy-a multicenter retrospective studyPrognostic risk classification for biochemical relapse-free survival in patients with oligorecurrent prostate cancer after [68Ga]PSMA-PET-guided metastasis-directed therapy
P50
description
researcher
@en
wetenschapper
@nl
name
Nina-Sophie Schmidt-Hegemann
@en
Nina-Sophie Schmidt-Hegemann
@nl
type
label
Nina-Sophie Schmidt-Hegemann
@en
Nina-Sophie Schmidt-Hegemann
@nl
prefLabel
Nina-Sophie Schmidt-Hegemann
@en
Nina-Sophie Schmidt-Hegemann
@nl
P31
P496
0000-0002-2091-3603